Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dexcom (DXCM) Other Operating Expenses (2018 - 2022)

Dexcom (DXCM) has disclosed Other Operating Expenses for 7 consecutive years, with -$5.7 million as the latest value for Q4 2022.

  • Quarterly Other Operating Expenses fell 106.72% to -$5.7 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was -$5.7 million through Sep 2023, down 106.3% year-over-year, with the annual reading at $87.1 million for FY2021, 3384.0% up from the prior year.
  • Other Operating Expenses for Q4 2022 was -$5.7 million at Dexcom, down from $1.8 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $217.7 million in Q4 2018, with the low at -$5.7 million in Q4 2022.
  • Average Other Operating Expenses over 5 years is $30.7 million, with a median of $1.8 million recorded in 2022.
  • The sharpest move saw Other Operating Expenses skyrocketed 4194304000000100.0% in 2020, then plummeted 106.72% in 2022.
  • Over 5 years, Other Operating Expenses stood at $217.7 million in 2018, then plummeted by 100.0% to -$0.0 in 2019, then surged by 4194304000000100.0% to $2.5 million in 2020, then skyrocketed by 3292.0% to $84.8 million in 2021, then crashed by 106.72% to -$5.7 million in 2022.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at -$5.7 million, $1.8 million, and $1.9 million for Q4 2022, Q3 2022, and Q2 2022 respectively.